Key Financial Data Of Reporting Company

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7576262

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
55,573,000,000 JPY
76,034,000,000 JPY
57,708,000,000 JPY
Ordinary profit (loss)
12,976,000,000 JPY
17,542,000,000 JPY
14,322,000,000 JPY
Net assets
140,704,000,000 JPY
138,325,000,000 JPY
139,692,000,000 JPY
Total assets
167,767,000,000 JPY
165,181,000,000 JPY
169,906,000,000 JPY
Basic earnings (loss) per share
243.31
84.99
251.43
269.41
93.20
Diluted earnings per share
Equity-to-asset ratio
0.835 xbrli:pure
0.834 xbrli:pure
0.819 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.